risedronate

Ligand id: 3176

Name: risedronate

IUPHAR Pharmacology Education Project (PEP) logo

View more information in the IUPHAR Pharmacology Education Project: risedronate

Structure and Physico-chemical Properties

2D Structure
Calculated Physico-chemical Properties
Hydrogen bond acceptors 8
Hydrogen bond donors 5
Rotatable bonds 4
Topological polar surface area 167.8
Molecular weight 283
XLogP -3
No. Lipinski's rules broken 0

Molecular properties generated using the CDK

References
1. Bergstrom JD, Bostedor RG, Masarachia PJ, Reszka AA, Rodan G. (2000)
Alendronate is a specific, nanomolar inhibitor of farnesyl diphosphate synthase.
Arch. Biochem. Biophys.373 (1): 231-41. [PMID:10620343]
2. Dunford JE, Kwaasi AA, Rogers MJ, Barnett BL, Ebetino FH, Russell RG, Oppermann U, Kavanagh KL. (2008)
Structure-activity relationships among the nitrogen containing bisphosphonates in clinical use and other analogues: time-dependent inhibition of human farnesyl pyrophosphate synthase.
J. Med. Chem.51 (7): 2187-95. [PMID:18327899]
3. Dunford JE, Thompson K, Coxon FP, Luckman SP, Hahn FM, Poulter CD, Ebetino FH, Rogers MJ. (2001)
Structure-activity relationships for inhibition of farnesyl diphosphate synthase in vitro and inhibition of bone resorption in vivo by nitrogen-containing bisphosphonates.
J. Pharmacol. Exp. Ther.296 (2): 235-42. [PMID:11160603]